Skip to main content
. 2009 May 29;4(5):e5728. doi: 10.1371/journal.pone.0005728

Figure 12. CD45 neutralization protects mouse splenocytes against the lethal effect of the trypanosomal non-cytosolic fraction in a dose-dependent way, provided the neutralizing mAb targets the epitope typical of CD45.2 rather than that characteristic of CD45.1.

Figure 12

Splenocytes were from C57BL/6 mice, which are homozygous for the CD45.2 genotype. Values are means±SD of three independent experiments.